Unknown

Dataset Information

0

Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury.


ABSTRACT: We evaluated whether LIM-kinase 2 inhibitor (LIMK2i) could improve erectile function by suppressing corporal fibrosis through the normalization of the Rho-associated coiled-coil protein kinase 1 (ROCK1)/LIMK2/Cofilin pathway in a rat model of cavernous nerve crush injury (CNCI). Sixty 11-week-old male Sprague-Dawley rats were divided equally into five groups: sham surgery (S), CNCI (I), and CNCI treated with low-dose (L), medium-dose (M), and high-dose (H) LIMK2i. The L, M, and H groups were treated with a daily intraperitoneal injection of LIMK2i (2.5, 5.0, and 10.0 mg kg-1 body weight, respectively) for 1 week after surgery. The erectile response was assessed using electrostimulation at 1 week, postoperatively. Penile tissues were processed for Masson's trichrome staining, double immunofluorescence, and Western blot assay. Erectile responses in the H group improved compared with the I group, while the M group showed only partial improvement. A significantly decreased smooth muscle/collagen ratio and an increased content of fibroblasts positive for phospho-LIMK2 were noted in the I group. The M and H groups revealed significant improvements in histological alterations and the dysregulated LIMK2/Cofilin pathway, except for LIMK2 phosphorylation in the M group. The inhibition of LIMK2 did not affect the ROCK1 protein expression. The content of fibroblasts positive for phospho-LIMK2 in the H group returned to the level found in the S group, whereas it did not in the M group. However, the L group did not exhibit such improvements. Our data suggest that the inhibition of LIMK2, particularly with administration of 10.0 mg kg-1 body weight LIMK2i, can improve corporal fibrosis and erectile function by normalizing the LIMK2/Cofilin pathway.

SUBMITTER: Park J 

PROVIDER: S-EPMC6038164 | biostudies-other | 2018 Jul-Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Role of inhibiting LIM-kinase2 in improving erectile function through suppression of corporal fibrosis in a rat model of cavernous nerve injury.

Park Juhyun J   Cho Sung Yong SY   Park Kwanjin K   Chai Ji Sun JS   Son Hwancheol H   Kim Soo Woong SW   Paick Jae-Seung JS   Cho Min Chul MC  

Asian journal of andrology 20180701 4


We evaluated whether LIM-kinase 2 inhibitor (LIMK2i) could improve erectile function by suppressing corporal fibrosis through the normalization of the Rho-associated coiled-coil protein kinase 1 (ROCK1)/LIMK2/Cofilin pathway in a rat model of cavernous nerve crush injury (CNCI). Sixty 11-week-old male Sprague-Dawley rats were divided equally into five groups: sham surgery (S), CNCI (I), and CNCI treated with low-dose (L), medium-dose (M), and high-dose (H) LIMK2i. The L, M, and H groups were tre  ...[more]

Similar Datasets

| S-EPMC3361063 | biostudies-other
| S-EPMC10478027 | biostudies-literature
| S-EPMC5628916 | biostudies-literature
| S-EPMC5736639 | biostudies-literature
| S-EPMC5578182 | biostudies-other
| S-EPMC7991820 | biostudies-literature
| S-EPMC10782119 | biostudies-literature
2012-12-31 | E-GEOD-31247 | biostudies-arrayexpress
| S-EPMC6862402 | biostudies-literature
| S-EPMC10652210 | biostudies-literature